Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms
(2023) In Acta Oncologica 62(5). p.431-437- Abstract
Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work-up and treatment of patients with lung- NEN has undergone major recent advances and new methods are currently being introduced into the clinic. These Nordic guidelines summarize and update the Nordic Neuroendocrine Tumor Group’s current view on how to diagnose and treat lung NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients. This review reflects our view of the current state of the art of diagnosis and treatment of patients with lung-NEN. Small cell lung carcinoma (SCLC) is not included in... (More)
Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work-up and treatment of patients with lung- NEN has undergone major recent advances and new methods are currently being introduced into the clinic. These Nordic guidelines summarize and update the Nordic Neuroendocrine Tumor Group’s current view on how to diagnose and treat lung NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients. This review reflects our view of the current state of the art of diagnosis and treatment of patients with lung-NEN. Small cell lung carcinoma (SCLC) is not included in these guidelines.
(Less)
- author
- organization
- publishing date
- 2023
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- bronchopulmonary neoplasm, diagnosis, Lung, neuroendocrine carcinoma, neuroendocrine neoplasm, treatment
- in
- Acta Oncologica
- volume
- 62
- issue
- 5
- pages
- 7 pages
- publisher
- Taylor & Francis
- external identifiers
-
- scopus:85159609658
- pmid:37194281
- ISSN
- 0284-186X
- DOI
- 10.1080/0284186X.2023.2212411
- language
- English
- LU publication?
- yes
- id
- 4bc1d676-8f8f-4e33-ace4-d7874fb02f46
- date added to LUP
- 2023-09-18 13:10:39
- date last changed
- 2024-12-14 02:36:13
@article{4bc1d676-8f8f-4e33-ace4-d7874fb02f46, abstract = {{<p>Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work-up and treatment of patients with lung- NEN has undergone major recent advances and new methods are currently being introduced into the clinic. These Nordic guidelines summarize and update the Nordic Neuroendocrine Tumor Group’s current view on how to diagnose and treat lung NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients. This review reflects our view of the current state of the art of diagnosis and treatment of patients with lung-NEN. Small cell lung carcinoma (SCLC) is not included in these guidelines.</p>}}, author = {{Dam, Gitte and Grønbæk, Henning and Sundlöv, Anna and Botling, Johan and Sundin, Anders and Petersen, Rene Horsleben and Welin, Staffan and Evensen, Espen Thiis and Sorbye, Halfdan and Tabaksblat, Elizaveta and Arveschoug, Anne Kirstine and Mortensen, Jann and Kjaer, Andreas and Knigge, Ulrich and Tiensuu Janson, Eva and Langer, Seppo W.}}, issn = {{0284-186X}}, keywords = {{bronchopulmonary neoplasm; diagnosis; Lung; neuroendocrine carcinoma; neuroendocrine neoplasm; treatment}}, language = {{eng}}, number = {{5}}, pages = {{431--437}}, publisher = {{Taylor & Francis}}, series = {{Acta Oncologica}}, title = {{Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms}}, url = {{http://dx.doi.org/10.1080/0284186X.2023.2212411}}, doi = {{10.1080/0284186X.2023.2212411}}, volume = {{62}}, year = {{2023}}, }